Pooled Effect-Size Between-studies heterogeneity was not significant for VR ( I 2 = 12.8%, Cochran's Q = 24.14, p = 0.19) and CVR ( I 2 = 0%, Cochran's Q = 14.33, p = 0.76) estimates, but as expected, for SMDH there was a significant between-studies heterogeneity ( I 2 = 47.4%, Cochran's Q = 37.15, p = 0.008)
Those with blood pressure concerns should monitor accordingly
It is therefore of great interest to investigate whether the same agents, and the same molecular targets, are of therapeutic relevance in OCD
GLOBAL GLUTATHIONE MARKET SIZE, BY HARD CAPSULES, BY REGION, 2018-2032 (USD MILLION) TABLE 167
Targeting pericytes for therapeutic approaches to neurological disorders
Kennedy mentioned that after the ban on certain products, a black market developed, resulting in the production of "very, very substandard" ingredients